(Q63408433)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15356916%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

CCR5 targeted SIV vaccination strategy preventing or inhibiting SIV infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15356916%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15356916%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

W M J M Bogers

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15356916%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

L A Bergmeier

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15356916%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

H Oostermeijer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15356916%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

P ten Haaft

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15356916%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Y Wang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15356916%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

C G Kelly

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15356916%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

M Singh

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15356916%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

T Lehner

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15356916%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

language of work or name

English

0 references

publication date

1 August 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15356916%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15356916%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15356916%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

23-24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15356916%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

2974-2984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15356916%20AND%20SRC:MED&resulttype=core&format=json

Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

Identification of a major co-receptor for primary isolates of HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

CD4-independent infection by HIV-2 is mediated by fusin/CXCR4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

Generation of CD8 suppressor factor and beta chemokines, induced by xenogeneic immunization, in the prevention of simian immunodeficiency virus infection in macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

beta-chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

Beta-chemokine production in macaques vaccinated with live attenuated virus correlates with protection against simian immunodeficiency virus (SIVsm) challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

Induction of inhibitory antibodies to the CCR5 chemokine receptor and their complementary role in preventing SIV infection in macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

Up-regulation of beta-chemokines and down-modulation of CCR5 co-receptors inhibit simian immunodeficiency virus transmission in non-human primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

Allo-immunization elicits CCR5 antibodies, SDF-1 chemokines, and CD8-suppressor factors that inhibit transmission of R5 and X4 HIV-1 in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

The CCR5 receptor acts as an alloantigen in CCR5Delta32 homozygous individuals: identification of chemokineand HIV-1-blocking human antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

Immunogenicity of the extracellular domains of C-C chemokine receptor 5 and the in vitro effects on simian immunodeficiency virus or HIV infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

Heat shock proteins generate beta-chemokines which function as innate adjuvants enhancing adaptive immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

Biochemical and antigenic characterization of the Mycobacterium tuberculosis 71kD antigen, a member of the 70kD heat-shock protein family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

C-C chemokines, pivotal in protection against HIV type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

AIDS preclinical vaccine development: biennial survey of HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

Endocytosis and recycling of the HIV coreceptor CCR5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

Specific incorporation of heat shock protein 70 family members into primate lentiviral virions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

A novel HIV-CCR5 receptor vaccine strategy in the control of mucosal SIV/HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

inferred from DOI database lookup

7 January 2021

based on heuristic

Induction of immune responses and break of tolerance by DNA against the HIV-1 coreceptor CCR5 but no protection from SIVsm challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.050

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2004.02.050

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15356916%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference